Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Jonsson Comprehensive Cancer Center
Poitiers University Hospital
National Cancer Institute (NCI)
Tempus AI